ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?

Kanekiyo, Takahisa, Xu, Huaxi, Bu, Guojun·2014·Neuron

Cited by (626)

Items 201–300 of 626

  1. Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
    Zhang, Lan, Xia, Yiyuan, Gui, Yuran · 2023 · Frontiers in Aging Neuroscience
  2. Resveratrol as a Therapeutic Agent in Alzheimer’s Disease: Evidence from Clinical Studies
    Nidhi Puranik, Meenakshi Kumari, Shraddha Tiwari, Thakur Dhakal, Minseok Song · 2025 · Nutrients
  3. Amyloid-β Reduces Exosome Release from Astrocytes by Enhancing JNK Phosphorylation
    Mohammad Abdullah, Hiroshi Takase, Mari Nunome, Hiroyuki Enomoto, Jin‐ichi Ito, Jian-Sheng Gong, Makoto Michikawa · 2016 · Journal of Alzheimer s Disease
  4. Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease
    Sofía Fernández de Retana, Alex Montañola, Paula Marazuela, Maialen De La Cuesta, Aina Batlle, Marc Fatar, Saskia Grudzenski, Joan Montaner, Mar Hernández‐Guillamón · 2017 · Neurobiology of Aging
  5. Diffuse Amyloid- β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons’ Brains Lacking Neuritic Amyloid Plaques
    Erin L. Abner, Janna H. Neltner, Gregory A. Jicha, Ela Patel, Sonya Anderson, Donna M. Wilcock, Linda J. Van Eldik, Peter T. Nelson · 2018 · Journal of Alzheimer s Disease
  6. Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer’s disease (AD) risk
    Sreedevi Raman, Nicholas Brookhouser, David A. Brafman · 2020 · Neurobiology of Disease
  7. ApoE4-Mediated Blood Brain Barrier Damage in Alzheimer's Disease: Progress and Prospects
    Xuebin Zhou, Qiyuan Shi, Xinyue Zhang, Lili Gu, Jinhua Li, Yue Ju, Min Hu, Xia Zhao, Qin Li · 2022 · Brain Research Bulletin
  8. Uremic Toxins, CKD, and Cognitive Dysfunction
    Taylor Andrews, Gregory Scott Day, Sarosh R. Irani, Takahisa Kanekiyo, LaTonya J. Hickson · 2025 · Journal of the American Society of Nephrology
  9. Protopanaxadiol derivative DDPU improves behavior and cognitive deficit in AD mice involving regulation of both ER stress and autophagy
    Xiaodan Guo, Jianlu Lv, Jian Lu, Lei Fan, Xi Huang, Lihong Hu, Jiaying Wang, Xu Shen · 2017 · Neuropharmacology
  10. Photoactivation of TGFβ/SMAD signaling pathway ameliorates adult hippocampal neurogenesis in Alzheimer’s disease model
    Xiaolei Wu, Qi Shen, Zhan Zhang, Di Zhang, Ying Gu, Da Xing · 2021 · Stem cell research & therapeutics
  11. Crossing borders in Alzheimer’s disease: A T cell’s perspective
    Lynn van Olst, Loet Coenen, Juliana M. Nieuwland, Carla Rodriguez-Mogeda, Nienke M. de Wit, Alwin Kamermans, Jinte Middeldorp, Helga E. de Vries · 2022 · Advanced Drug Delivery Reviews
  12. Amyloid-Related Memory Decline in Preclinical Alzheimer’s Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months
    Christine Thai, Yen Ying Lim, Victor L. Villemagne, Simon Matthew Laws, David J. Ames, Kathryn A. Ellis, Stephanie Ruth Rainey‐Smith, Ralph Nigel Martins, Colin Louis Masters, Christopher C. Rowe et al. · 2015 · PLoS ONE
  13. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals
    Yen Ying Lim, Robert Williamson, Simon Matthew Laws, Victor L. Villemagne, Pierrick Bourgeat, Christopher James Fowler, Stephanie Ruth Rainey‐Smith, Olivier Salvado, Ralph Nigel Martins, Christopher Cleon Rowe et al. · 2017 · Journal of Alzheimer s Disease
  14. The Role of Apolipoprotein E Isoforms in Alzheimer’s Disease
    Alejandro R. Roda, Laia Montoliu‐Gaya, Sandra Villegas · 2019 · Journal of Alzheimer s Disease
  15. Physical activity and beta-amyloid pathology in Alzheimer's disease: A sound mind in a sound body
    K. Ebrahimi, Alireza Majdi, Behrouz Baghaiee, S. H. Hosseini, S. Sadigh-Eteghad · 2017 · EXCLI Journal : Experimental and Clinical Sciences
  16. Exercise as Potential Therapeutic Target to Modulate Alzheimer’s Disease Pathology in APOE ε4 Carriers: A Systematic Review
    Sevilay Tokgöz, Jurgen A.H.R. Claassen · 2021 · Cardiology and Therapy
  17. Microglia‐specific <scp>ApoE</scp> knock‐out does not alter Alzheimer's disease plaque pathogenesis or gene expression
    Henningfield, Caden M., Arreola, Miguel A., Soni, Neelakshi, Spangenberg, Elizabeth E., Green, Kim N. · 2022 · Glia
  18. Common Pesticide, Dichlorodiphenyltrichloroethane (DDT), Increases Amyloid-β Levels by Impairing the Function of ABCA1 and IDE: Implication for Alzheimer’s Disease
    Li, Gongbo, Kim, Chaeyoung, Kim, Jaekwang, Yoon, Hyejin, Zhou, Huadong, Kim, Jungsu · 2015 · Journal of Alzheimer's Disease
  19. Multi-functional role of apolipoprotein E in neurodegenerative diseases
    Sadequl Islam, A. Noorani, Yang Sun, Makoto Michikawa, Kun Zou · 2025 · Frontiers in Aging Neuroscience
  20. Apolipoprotein E-mediated regulation of selenoprotein P transportation via exosomes
    Jin, Yunjung, Chung, Youn Wook, Jung, Min Kyo, Lee, Jea Hwang, Ko, Kwan Young, Jang, Jun Ki, Ham, Minju, Kang, Hyunwoo, Pack, Chan Gi, Mihara, Hisaaki et al. · 2020 · Cellular and Molecular Life Sciences
  21. Neurotrophins as Key Regulators of Cell Metabolism: Implications for Cholesterol Homeostasis
    Mayra Colardo, Noemi Martella, Daniele Pensabene, Silvia Siteni, Sabrina Di Bartolomeo, Valentina Pallottini, Marco Segatto · 2021 · International Journal of Molecular Sciences
  22. Amyloid beta increases ABCA1 and HMGCR protein expression, and cholesterol synthesis and accumulation in mice neurons and astrocytes
    Shirin Azizidoost, Hossein Babaahmadi‐Rezaei, Zahra Nazeri, Maryam Cheraghzadeh, Alireza Kheirollah · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  23. Bidirectional Communication Between the Brain and Other Organs: The Role of Extracellular Vesicles
    Wu Zhou, Lihong Zhao, Zelu Mao, Zhihua Wang, Zhixiong Zhang, Meihua Li · 2023 · Cellular and Molecular Neurobiology
  24. The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
    Dustin Chernick, Rui Zhong, Ling Li · 2020 · Biomolecules
  25. Opposing effects ofApoe/Apoa1double deletion on amyloid-β pathology and cognitive performance in APP mice
    Nicholas Francis Fitz, Vı́ctor Tapias, Andrea A. Cronican, Emilie L. Castranio, Muzamil Saleem, Alexis Y. Carter, Martina I. Lefterova, Iliya M. Lefterov, Radosveta P. Koldamova · 2015 · Brain
  26. The Continuing Failure of Bexarotene in Alzheimer’s Disease Mice
    Claudia Balducci, Alessandra Paladini, Edoardo Micotti, Daniele Tolomeo, Pietro La Vitola, Emanuele Grigoli, Jill C. Richardson, Gianluigi Forloni · 2015 · Journal of Alzheimer s Disease
  27. Aβ-related memory decline in APOE ε4 noncarriers
    Yen Ying Lim, Simon Matthew Laws, Victor L. Villemagne, Robert H. Pietrzak, Tenielle Porter, David J. Ames, Christopher James Fowler, Stephanie Ruth Rainey‐Smith, Peter Jeffrey Snyder, Ralph Nigel Martins et al. · 2016 · Neurology
  28. Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment
    Laia Montoliu‐Gaya, Sandra Villegas · 2016 · Expert Reviews in Molecular Medicine
  29. Emerging Role of microRNAs in Dementia
    Sarayu Ramakrishna, Ravi Sondekoppa Muddashetty · 2019 · Journal of Molecular Biology
  30. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β
    Amanda B. Chai, Hin Hei Julian Lam, Maaike Kockx, Ingrid C. Gelissen · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  31. Amyloid and Tau PET Imaging of Alzheimer Disease and Other Neurodegenerative Conditions
    Paul A. Rowley, Alexey A. Samsonov, Tobey J. Betthauser, Ali Pirasteh, Sterling C. Johnson, Laura B. Eisenmenger · 2020 · Seminars in Ultrasound CT and MRI
  32. The ABC's of Alzheimer risk gene ABCA7
    Lena Duchateau, Nicole Wawrzyniak, Kristel Sleegers · 2024 · Alzheimer s & Dementia
  33. Iron metabolism in diabetes-induced Alzheimer’s disease: a focus on insulin resistance in the brain
    Ji Yeon Chung, Hyung-Seok Kim, Juhyun Song · 2018 · BioMetals
  34. Electrochemical detection of specific interactions between apolipoprotein E isoforms and DNA sequences related to Alzheimer’s disease
    Dhésmon Lima, Ana Carolina Mendes Hacke, Juliana Inaba, Christiana Andrade Pessôa, Kağan Kerman · 2019 · Bioelectrochemistry
  35. An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease
    Amy F.T. Arnsten, Kelly Del Tredici, Nicolas R. Barthélemy, Mariano I. Gabitto, Christopher H. van Dyck, Edward S. Lein, Heiko Braak, Dibyadeep Datta · 2025 · Alzheimer s & Dementia
  36. Dysregulated Metabolism of the Amyloid‐β Protein and Therapeutic Approaches in Alzheimer Disease
    Kazunori Kikuchi, Kiwami Kidana, Takuya Tatebe, Taisuke Tomita · 2017 · Journal of Cellular Biochemistry
  37. The Interplay Between Apolipoprotein E4 and the Autophagic–Endocytic–Lysosomal Axis
    Schmukler, E., Michaelson, D. M., Pinkas-Kramarski, R. · 2018 · Molecular Neurobiology
  38. Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases
    Juno S. Van Valkenburgh, Cristiana Joy Meuret, Ashley E. Martinez, Vibha Kodancha, Victoria A. Solomon, Kai Chen, Hussein N. Yassine · 2021 · Frontiers in Physiology
  39. Towards Personalized Intervention for Alzheimer’s Disease
    Xing Peng, Peiqi Xing, Xiuhui Li, Ying Qian, Fuhai Song, Zhouxian Bai, Guangchun Han, Hongxing Lei · 2016 · Genomics Proteomics & Bioinformatics
  40. β-hydroxybutyrate Impedes the Progression of Alzheimer’s Disease and Atherosclerosis in ApoE-Deficient Mice
    Manigandan Krishnan, Jong Su Hwang, Mi Kyung Kim, Yun Jin Kim, Ji Hae Seo, Jeeyoun Jung, Eunyoung Ha · 2020 · Nutrients
  41. Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer’s Disease?
    Juan Francisco Codocedo, Juvenal A. Ríos, Juan Alejandro Godoy, Nibaldo C. Inestrosa · 2015 · Molecular Neurobiology
  42. Relation between plasma and brain lipids
    Wellington, Cheryl L., Frikke-Schmidt, Ruth · 2016 · Current Opinion in Lipidology
  43. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non–Alzheimer Disease Pathophysiology
    Stefanie Schreiber, Frank Schreiber, Samuel Neal Lockhart, Andy Horng, Alexandre Bejanin, Susan M. Landau, William J. Jagust, Alzheimer’s Disease Neuroimaging Initiative · 2017 · JAMA Neurology
  44. ApoE-fragment/Aβ heteromers in the brain of patients with Alzheimer’s disease
    Amandine Mouchard, Marie-Charlotte Boutonnet, Claire Mazzocco, Nathalie Biendon, Nathalie Macrez, Neuro-CEB Neuropathology Network · 2019 · Scientific Reports
  45. Integrated approach reveals diet, APOE genotype and sex affect immune response in APP mice
    Nam, Kyong Nyon, Wolfe, Cody M., Fitz, Nicholas F., Letronne, Florent, Castranio, Emilie L., Mounier, Anais, Schug, Jonathan, Lefterov, Iliya, Koldamova, Radosveta · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  46. Ageing related thyroid deficiency increases brain-targeted transport of liver-derived ApoE4-laden exosomes leading to cognitive impairment
    Manman Zhang, Wenliang Gong, Dianjun Zhang, Ming Hua Ji, Binjie Chen, Beina Chen, Xinyu Li, Yuefei Zhou, Chengyi Dong, Gehua Wen et al. · 2022 · Cell Death and Disease
  47. Efficient creation of an APOE knockout rabbit
    Diana Ji, Guojun Zhao, Allison E. Songstad, Xiaoxia Cui, Edward J. Weinstein · 2014 · Transgenic Research
  48. Trans-Synaptic Spread of Amyloid-βin Alzheimer’s Disease: Paths toβ-Amyloidosis
    Annabella Pignataro, Silvia Middei · 2017 · Neural Plasticity
  49. Sortilin-Related Receptor Expression in Human Neural Stem Cells Derived from Alzheimer’s Disease Patients Carrying the APOE Epsilon 4 Allele
    Alen Zollo, Zoe Allen, Helle Foverskov Rasmussen, Filomena Iannuzzi, Yichen Shi, Agnete Larsen, Thorsten J. Maier, Carmela Matrone · 2017 · Neural Plasticity
  50. Revisiting the Role of Insulin-Like Growth Factor-I Receptor Stimulating Activity and the Apolipoprotein E in Alzheimer’s Disease
    Sara A. Galle, Ashley van der Spek, Madeleine L. Drent, Michael P. Brugts, Erik Scherder, J. A. M. J. L. Janssen, M. Arfan Ikram, Cornelia M. van Duijn · 2019 · Frontiers in Aging Neuroscience
  51. The dark side of Alzheimer’s disease: unstructured biology of proteins from the amyloid cascade signaling pathway
    Kundlik Gadhave, Bhuvaneshwari R. Gehi, Prateek Kumar, Bin Xue, Vladimir Nikolaevich Uversky, Rajanish Giri · 2020 · Cellular and Molecular Life Sciences
  52. Electrochemical immunosensor based on AuBP@Pt nanostructure and AuPd-PDA nanozyme for ultrasensitive detection of APOE4
    Yibiao Liu, Guangli He, Huili Liu, Hang Yin, Fengli Gao, Jian Chen, Shouren Zhang, Baocheng Yang · 2020 · RSC Advances
  53. Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model
    Zhenqing Liu, Jianfei Chao, Cheng Wang, Guihua Sun, Daniel Roeth, Wei Liu, Xianwei Chen, Li Li, Erpo Tian, Lizhao Feng et al. · 2023 · Cell Reports
  54. APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults
    Chelsea C. Hays, Zvinka Z. Zlatar, Mary J. Meloy, Mark William Bondi, Paul E. Gilbert, Thomas T. Liu, Jonathan Lee Helm, Christina E. Wierenga · 2019 · NeuroImage
  55. Microglia and its Genetics in Alzheimer's Disease
    Xinyan Liang, Haijian Wu, Mark Colt, Xinying Guo, Brock R. Pluimer, Jianxiong Zeng, Shupeng Dong, Zhen Zhao · 2021 · Current Alzheimer Research
  56. Pathogenesis of Alzheimer’s Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential
    Atamjit Singh, Karanvir Singh, Jashandeep Kaur, Ramanpreet Kaur, Aman Sharma, Jasleen Kaur, Uttam Kaur, Renu Chadha, Preet Mohinder Singh Bedi · 2023 · ACS Chemical Neuroscience
  57. Role of LDL Cholesterol and Endolysosomes in Amyloidogenesis and Alzheimer’s Disease
    Xuesong Chen · 2014 · Journal of Neurology & Neurophysiology
  58. Cholesterol Metabolism in Neurodegenerative Diseases
    Keqiang He, Zhiwei Zhao, Juan Zhang, Ding-Feng Li, Sheng Wang, Qiang Liu · 2024 · Antioxidants and Redox Signaling
  59. Associations Between ApoEε4 Carrier Status and Serum BDNF Levels—New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer’s Disease
    Yu-Hui Liu, Shu‐Sheng Jiao, Ye‐Ran Wang, Xian‐Le Bu, Xiu‐Qing Yao, Yang Xiang, Qing-Hua Wang, Lin Wang, Juan Deng, Jing Li et al. · 2014 · Molecular Neurobiology
  60. ABCA7 polymorphisms correlate with memory impairment and default mode network in patients with APOEε4-associated Alzheimer’s disease
    Ya‐Ting Chang, Shih‐Wei Hsu, Shu‐Hua Huang, Chi‐Wei Huang, Wen‐Neng Chang, Chia-Yi Lien, Jun‐Jun Lee, Chen‐Chang Lee, Chiung‐Chih Chang · 2019 · Alzheimer s Research & Therapy
  61. Role of non‑coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)
    Katerina Pierouli, Eleni Papakonstantinou, Louis Papageorgiou, Io Diakou, Τhanasis Mitsis, Konstantina Dragoumani, Demetrios A. Spandidos, Flora Bacopoulou, George Panagiotis Chrousos, George N. Goulielmos et al. · 2022 · International Journal of Molecular Medicine
  62. White matter injury, cholesterol dysmetabolism, and APP/Abeta dysmetabolism interact to produce Alzheimer’s disease (AD) neuropathology: A hypothesis and review
    Frank R. Sharp, Charles S DeCarli, Lee‐Way Jin, Xinhua Zhan · 2023 · Frontiers in Aging Neuroscience
  63. ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity
    Ioannis Dafnis, Christina Raftopoulou, Christina Mountaki, Evgenia V. Megalou, Vassilis I. Zannis, Angeliki Chroni · 2018 · Biochemical Journal
  64. Lipid metabolism and neuroinflammation: What is the link?
    Vini Tiwari, Mikael Simons · 2025 · The Journal of Experimental Medicine
  65. Advances in Modeling Alzheimer's Disease In Vitro
    Navatha Shree Sharma, Anik Karan, Dong-Hee Lee, Zheng Yan, Jingwei Xie · 2021 · Advanced NanoBiomed Research
  66. A whole-process interpretable and multi-modal deep reinforcement learning for diagnosis and analysis of Alzheimer’s disease ∗
    Quan Zhang, Qian Du, Guohua Liu · 2021 · Journal of Neural Engineering
  67. Sex‐Related Differences in Rat Choroid Plexus and Cerebrospinal Fluid: A cDNA Microarray and Proteomic Analysis
    Telma Quintela, Helena Marcelino, Michael J. Deery, Renata Feret, J. Howard, Kathryn Susan Lilley, Tânia Albuquerque, Isabel Gonçalves, Ana Catarina Duarte, Cecília R.A. Santos · 2015 · Journal of Neuroendocrinology
  68. Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer’s Disease
    Saul, Anika, Wirths, Oliver · 2017 · Molecular Neurobiology
  69. Brain-derived neurotrophic factor interplay with oxidative stress: neuropathology approach in potential biomarker of Alzheimer’s disease
    Robert Shen, Christian Ardianto, Celia Celia, Veronika Maria Sidharta, Poppy Kristina Sasmita, Irawan Satriotomo, Yuda Turana · 2023 · Dementia & Neuropsychologia
  70. The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases
    Arazu Sharif, John C.L. Mamo, Virginie Lam, Hani Al‐Salami, Armin Mooranian, Gerald Francis Watts, Roger Clarnette, Giuseppe Luna, Ryusuke Takechi · 2024 · Translational Neurodegeneration
  71. The Role of Estrogen across Multiple Disease Mechanisms
    Xiuting Xiang, Praneetha Palasuberniam, Rahmawati Binti Pare · 2024 · Current Issues in Molecular Biology
  72. A mouse model of chemotherapy-related cognitive impairments integrating the risk factors of aging and APOE4 genotype
    Tamar C. Demby, Olga Catalina Rodriguez, Camryn W. McCarthy, Yi‐Chien Lee, Christopher Albanese, Jeanne S. Mandelblatt, George William Rebeck · 2020 · Behavioural Brain Research
  73. Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer's disease
    Julia Pfeil, Merle C. Hoenig, Elena Doering, Thilo van Eimeren, Alexander E. Drzezga, Gérard N. Bischof · 2021 · Neurobiology of Aging
  74. ABCA1 Deficiency Affects Basal Cognitive Deficits and Dendritic Density in Mice
    Nicholas Francis Fitz, Alexis Y. Carter, Vı́ctor Tapias, Emilie L. Castranio, Ravindra B. Kodali, Iliya M. Lefterov, Radosveta P. Koldamova · 2017 · Journal of Alzheimer s Disease
  75. Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies
    Kalarickal Vijayan Dileep, Remya Chandra · 2019 · Current Drug Targets
  76. Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease
    Szu-Ying Lin, Kun‐Ju Lin, Po-Chen Lin, Chin-Chang Huang, Chiung‐Chih Chang, Yi‐Chung Lee, Ing‐Tsung Hsiao, Tzu‐Chen Yen, Wen-Sheng Huang, Bang‐Hung Yang et al. · 2019 · Alzheimer s Research & Therapy
  77. Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes
    Anna Vasilevskaya, Foad Taghdiri, Charles Burke, Apameh Tarazi, Seyed Ali Naeimi, Mozghan Khodadadi, Ruma Goswami, Christine Sato, Mark Grinberg, Danielle Moreno et al. · 2020 · NeuroImage Clinical
  78. Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer’s disease
    Charis Ringland, Jonas Elias Schweig, Daniel Paris, Ben Shackleton, Cillian Lynch, Maxwell Eisenbaum, MICHAEL J. MULLAN, Fiona Crawford, Laila I. Abdullah, Corbin J. Bachmeier · 2020 · Neurobiology of Aging
  79. Severe Obstructive Sleep Apnea and Increased Cortical Amyloid-β Deposition
    Salla Ylä-Herttuala, Mikko A. Hakulinen, Pekka Poutiainen, Tiina M. Laitinen, Anne Maria Koivisto, Anne Marja Remes, Merja Hallikainen, Juha-Matti Lehtola, Toni Tapani Saari, Ville E. Korhonen et al. · 2020 · Journal of Alzheimer s Disease
  80. LRP1 in vascular mural cells modulates cerebrovascular integrity and function in the presence of APOE4
    Hiroshi Oue, Yu Yamazaki, Wenhui Qiao, Chen Yuanxin, Yingxue Ren, Aishe Kurti, Francis Shue, Tammee M. Parsons, Ralph B. Perkerson, Keiji Kawatani et al. · 2023 · JCI Insight
  81. The novel function of bexarotene for neurological diseases
    Yangtao Liu, Pengwei Wang, Guofang Jin, Peijie Shi, Yonghui Zhao, Jiayi Guo, Yaling Yin, Qian-Hang Shao, Peng Li, Pengfei Yang · 2023 · Ageing Research Reviews
  82. APOE4 reprograms microglial lipid metabolism in Alzheimer's disease: Mechanisms and therapeutic implications
    Jiajie Chen, Shuoyan Zhao, Yingying Zhou, Luyao Wang, Qin Chen, Kai Zheng · 2025 · BioScience Trends
  83. Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice
    Alexis Y. Carter, Florent Letronne, Nicholas Francis Fitz, Anaïs Mounier, Cody M. Wolfe, Kyong Nyon Nam, Valerie L. Reeves, Hafsa Kamboh, Iliya M. Lefterov, Radosveta P. Koldamova · 2017 · PLoS ONE
  84. Impaired autophagy in amyloid-beta pathology: A traditional review of recent Alzheimer's research
    Minghao Yuan, Yangyang Wang, Zhenting Huang, Feng Jing, Peifeng Qiao, Qian Zou, Jing Li, Zhiyou Cai · 2022 · Journal of Biomedical Research
  85. Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases
    Rolf Antonie Loch, Hongzhi Wang, Alex Perálvarez‐Marín, Philipp Berger, Henrietta M. Nielsen, Angeliki Chroni, Jinghui Luo · 2023 · Computational and Structural Biotechnology Journal
  86. APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease
    Gunel Ayyubova · 2023 · CNS & Neurological Disorders - Drug Targets
  87. Aβ Clearance, “hub” of Multiple Deficiencies Leading to Alzheimer Disease
    Pasquale Gallina, Antonio Scollato, Renato Conti, Nicola Di Lorenzo, Berardino Porfirio · 2015 · Frontiers in Aging Neuroscience
  88. Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer’s disease
    Mitsuru Shinohara, Shunsuke Koga, Takuya Konno, Jeremy Nix, Motoko Shinohara, Naoya Aoki, Pritam Das, Joseph E. Parisi, Ronald Carl Petersen, Terrone L. Rosenberry et al. · 2017 · Brain
  89. Associations Between APOE Variants, Tau and α-Synuclein
    Elena Rodriguez‐Vieitez, Henrietta M. Nielsen · 2019 · Advances in experimental medicine and biology
  90. Presenilin Is Essential for ApoE Secretion, a Novel Role of Presenilin Involved in Alzheimer's Disease Pathogenesis
    Sadequl Islam, Yang Sun, Yuan Gao, Tomohisa Nakamura, A. Noorani, Tong Li, P. Wong, Noriyuki Kimura, E. Matsubara, K. Kasuga et al. · 2022 · Journal of Neuroscience
  91. Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
    Stephanie R. Oatman, Joseph S. Reddy, Zachary Quicksall, Minerva M. Carrasquillo, Xue Wang, Chia‐Chen Liu, Yu Yamazaki, Thuy Nguyen, Kimberly G. Malphrus, Michael G. Heckman et al. · 2023 · Molecular Neurodegeneration
  92. Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease
    María F. Colavitta, Francisco José Barrantes · 2023 · Pharmaceutics
  93. Bridging the age spectrum of neurodegenerative storage diseases
    Barry Boland, Frances M. Platt · 2014 · Best Practice & Research Clinical Endocrinology & Metabolism
  94. 5-HT3 Antagonist Ondansetron Increases apoE Secretion by Modulating the LXR-ABCA1 Pathway
    Motoko Shinohara, Mitsuru Shinohara, Jing Zhao, Yuan Fu, Chia‐Chen Liu, Takahisa Kanekiyo, Guojun Bu · 2019 · International Journal of Molecular Sciences
  95. APOE4 impairs autophagy and Aβ clearance by microglial cells
    Bassal, Rawan, Rivkin-Natan, Maria, Rabinovich, Alon, Michaelson, Daniel Moris, Frenkel, Dan, Pinkas-Kramarski, Ronit · 2025 · Inflammation Research
  96. SORL1 gene polymorphism association with late-onset Alzheimer’s disease
    Xialu Feng, Deren Hou, Yanyao Deng, Wei Li, Mi Tian, Zhuling Yu · 2014 · Neuroscience Letters
  97. Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase
    Ai Sze Wee, Thao Dinh Nhu, Kooi Yeong Khaw, Kim San Tang, Keng Yoon Yeong · 2022 · Current Neuropharmacology
  98. Soluble and insoluble protein aggregates, endoplasmic reticulum stress, and vascular dysfunction in Alzheimer’s disease and cardiovascular diseases
    Emily W. Waigi, Robert Clinton Webb, Melissa A. Moss, Mark J. Uline, Cameron Grant McCarthy, Camilla Ferreira Wenceslau · 2023 · GeroScience
  99. APOE4-promoted gliosis and degeneration in tauopathy are ameliorated by pharmacological inhibition of HMGB1 release
    Nicole Koutsodendris, Jessica R. Blumenfeld, Ayushi Agrawal, Michela Traglia, Oscar Yip, Antara T. Rao, Min Joo Kim, Maxine R. Nelson, Yung-Hua Wang, Brian P. Grone et al. · 2023 · Cell Reports
  100. Apolipoprotein 4 may increase viral load and seizure frequency in mesial temporal lobe epilepsy patients with positive human herpes virus 6B
    Cheng Yu Huang, Bo Yan, Ding Lei, Yang Si, Li He, Ming-Wan Chen, Li Li, Fei Chen, Qiao Zhou, Dong Zhou et al. · 2015 · Neuroscience Letters